The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.

Plus, activist investor Starboard Value has built a $1bn position in struggling drugmaker Pfizer, and tens of thousands of striking machinists are threatening Boeing’s recovery. “You only go to the ...

Steven Bailey will replace incumbent Gary Swidler, who has been in the role for nearly a decade, on March 31. Swidler would, ...